-
5 July 2010 - Paris (France)
21th Neuronal Plasticity Prize awarded to three eminent scientists for their research into the domain of the Neuroendocrine Control of Behavior: Thomas R. Insel, Bruce McEwen and Donald Pfaff
-
26 June 2010 - Paris (France)
Ipsen’s partner Roche confirms the promising efficacy profile of Taspoglutide
-
22 June 2010 - Paris (France)
Encouraging results of GuidAge®, large scale European trial conducted in the prevention of Alzheimer’s Dementia
-
18 June 2010 - Paris (France)
Ipsen’s partner Roche announces amendment of the trial protocols for the taspoglutide phase III programme
-
17 June 2010 - Paris (France) and Laguna Niguel (CA, USA)
OBI-1 developed by Ipsen and Inspiration has obtained a positive opinion for the orphan drug status in Europe
-
9 June 2010 - Paris (France)
Implementation of a Sponsored Level I American Depositary Receipt (ADR) program: A new step in Ipsen's development in the United States
-
28 May 2010 - Paris (France)
Combined Shareholders’ Meeting of Ipsen S.A. held on 28 May 2010
-
11 May 2010 - Paris (France)
6th Colloque Médecine et Recherche of the Fondation Ipsen in the Cancer Science series: “Stem Cells and Cancer”
-
4 May 2010 - Paris (France)
25th Colloque Médecine et Recherche of the Fondation Ipsen in the series Alzheimer Disease: “Two Faces of Evil: Cancer and Neurodegeneration”
-
4 May 2010 - Paris (France)
18th Colloque Médecine et Recherche of the Fondation Ipsen in the Neurosciences series: “Characterizing Consciousness: From Cognition to the Clinic ? »”